Belgium Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Belgium Pharmaceuticals and Healthcare Report Q3 2013 Jul 17th 2013, 00:00, by rnrmahesh BMI View: We continue to expect a year-on-year (y-o-y) contraction in the value of the Belgian pharmaceutical market in 2013, as public expenditure continues to be challenged by the need for cost containment. While high per capita consumption of medicines continue to offer opportunities for researchbased pharmaceutical companies, risks will remain elevated, especially given the current economic backdrop. Headline Expenditure Projections ? Pharmaceuticals: EUR5.96bn (US$7.57bn) in 2012 to EUR5.85bn (US$7.85bn) in 2013; -1.80% in local currency terms and +3.6% in US dollar terms. Local currency forecast virtually unchanged from Q213. ? Healthcare: EUR40.37bn (US$51.26bn) in 2012 to EUR41.20bn (US$55.21bn) in … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=107747. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/belgium-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions